Profile data is unavailable for this security.
About the company
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
- Revenue in USD (TTM)0.00
- Net income in USD-11.28m
- Incorporated2017
- Employees16.00
- LocationNeurosense Therapeutics Ltd11 Hamenofim St., Building BHERZLIYA 4672562IsraelISR
- Phone+972 99531142
- Websitehttps://www.neurosense-tx.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GlycoMimetics Inc | 10.00k | -37.28m | 19.21m | 35.00 | -- | -- | -- | 1,920.62 | -0.5791 | -0.5791 | 0.0002 | -- | 0.0002 | -- | -- | 285.71 | -72.29 | -43.60 | -81.84 | -47.82 | -- | -- | -372,767.40 | -2,243.52 | -- | -- | 0.00 | -- | -86.67 | -- | 20.97 | -- | -29.82 | -- |
| Bioxytran Inc | 0.00 | -4.30m | 19.25m | 2.00 | -- | -- | -- | -- | -0.0297 | -0.0297 | 0.00 | -0.0017 | 0.00 | -- | -- | -- | -2,431.80 | -1,420.53 | -- | -- | -- | -- | -- | -- | -- | -7.69 | -- | -- | -- | -- | -73.71 | -- | -- | -- |
| Neurobo Pharmaceuticals Inc | 0.00 | -12.47m | 19.60m | 8.00 | -- | 1.17 | -- | -- | -2.71 | -2.71 | 0.00 | 3.40 | 0.00 | -- | -- | 0.00 | -44.29 | -95.57 | -64.66 | -135.64 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 10.72 | -- | 75.54 | -- |
| Evaxion Biotech A/S - ADR | 73.00k | -22.13m | 19.66m | 49.00 | -- | -- | -- | 269.33 | -81.29 | -81.29 | 0.2665 | -1.25 | 0.0042 | -- | 0.091 | 1,489.80 | -126.74 | -100.11 | -183.85 | -131.65 | -- | -- | -30,308.22 | -131,560.30 | -- | -30.92 | 1.77 | -- | -- | -- | 4.51 | -- | 65.53 | -- |
| Zivo Bioscience Inc | 27.65k | -7.78m | 19.76m | 8.00 | -- | -- | -- | 714.69 | -4.62 | -4.62 | 0.0163 | -0.9259 | 0.0206 | -- | -- | 3,456.25 | -580.66 | -376.60 | -- | -- | 41.99 | -- | -28,127.23 | -96,315.32 | -- | -97.39 | -- | -- | -- | -- | 11.07 | -- | -- | -- |
| Goldenwell Biotech Inc | 2.34k | -116.90k | 19.80m | -- | -- | 233.71 | -- | 8,461.54 | -0.0012 | -0.0012 | 0.00002 | 0.0009 | 0.0098 | 0.0071 | -- | -- | -49.07 | -- | -52.16 | -- | 47.01 | -- | -4,995.73 | -- | 37.75 | -- | 0.00 | -- | -95.10 | -- | 88.13 | -- | -- | -- |
| Biomx Inc | 0.00 | -26.17m | 19.88m | 58.00 | -- | 5.37 | -- | -- | -0.5433 | -0.5433 | 0.00 | 0.067 | 0.00 | -- | -- | 0.00 | -74.18 | -- | -101.74 | -- | -- | -- | -- | -- | -- | -21.95 | 0.7841 | -- | -- | -- | 7.59 | -- | -- | -- |
| Neurosense Therapeutics Ltd | 0.00 | -11.28m | 20.35m | 16.00 | -- | -- | -- | -- | -0.7625 | -0.7625 | 0.00 | -0.1219 | 0.00 | -- | -- | 0.00 | -207.24 | -- | -395.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 8.59 | -- | -- | -- |
| MEI Pharma Inc | 72.65m | 19.84m | 20.45m | 46.00 | 1.03 | 0.3439 | 1.01 | 0.2816 | 2.98 | 2.98 | 10.90 | 8.93 | 0.6425 | -- | 25.47 | 1,579,304.00 | 17.55 | -25.31 | 20.31 | -28.59 | -- | -- | 27.32 | -122.05 | -- | -- | 0.00 | -- | 19.95 | 97.56 | 41.53 | -- | -- | -- |
| Inhibitor Therapeutics Inc | 0.00 | -3.03m | 20.75m | 3.00 | -- | 3.93 | -- | -- | -0.0176 | -0.0176 | 0.00 | 0.0307 | 0.00 | -- | -- | 0.00 | -28.92 | 27.48 | -30.91 | 32.70 | -- | -- | -- | -- | -- | -- | 0.00 | 0.00 | -- | -- | -125.39 | -- | -- | -- |
| Sol Gel Technologies Ltd | 1.55m | -27.24m | 20.75m | 36.00 | -- | 0.537 | -- | 13.36 | -1.02 | -1.02 | 0.0574 | 1.39 | 0.0338 | -- | 0.3774 | 43,166.67 | -59.27 | -31.60 | -64.80 | -35.49 | -- | -- | -1,752.77 | -135.76 | -- | -- | 0.00 | -- | -59.98 | 64.50 | -82.52 | -- | -33.78 | -- |
| Synlogic Inc | 3.37m | -57.28m | 21.28m | 6.00 | -- | 0.3941 | -- | 6.31 | -11.41 | -11.41 | 0.6581 | 4.64 | 0.0362 | -- | -- | 561,833.30 | -61.46 | -40.57 | -74.45 | -43.82 | -- | -- | -1,699.26 | -3,245.93 | -- | -- | 0.00009 | -- | 185.68 | 5.99 | 13.40 | -- | -48.05 | -- |
| Alaunos Therapeutics Inc | 5.00k | -35.14m | 21.30m | 1.00 | -- | 3.38 | -- | 4,259.32 | -2.20 | -2.20 | 0.0003 | 0.3939 | 0.0001 | -- | 2.00 | 5,000.00 | -96.01 | -74.83 | -149.28 | -89.57 | -- | -- | -702,800.00 | -10,508.06 | -- | -14.83 | 0.00 | -- | -99.83 | -49.08 | 6.86 | -- | -15.56 | -- |
| NanoViricides Inc | 0.00 | -9.36m | 21.56m | 7.00 | -- | 1.86 | -- | -- | -0.8004 | -0.8004 | 0.00 | 0.9828 | 0.00 | -- | -- | 0.00 | -55.47 | -43.54 | -57.90 | -46.29 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -5.94 | -- | -8.90 | -- |
| Polypid Ltd | 0.00 | -23.87m | 21.59m | 59.00 | -- | -- | -- | -- | -19.44 | -19.44 | 0.00 | -1.27 | 0.00 | -- | -- | 0.00 | -115.45 | -76.92 | -187.15 | -89.61 | -- | -- | -- | -- | -- | -24.61 | 1.25 | -- | -- | -- | 39.67 | -- | -42.34 | -- |
Data as of May 09 2024. Currency figures normalised to Neurosense Therapeutics Ltd's reporting currency: US Dollar USD
0.84%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Meitav Mutual Funds Ltd.as of 31 Mar 2024 | 50.00k | 0.37% |
| Schiketanz Capital Advisors GmbHas of 29 Dec 2023 | 18.60k | 0.14% |
| HRT Financial LLCas of 31 Dec 2023 | 14.00k | 0.10% |
| Scientech Research LLCas of 31 Dec 2023 | 12.58k | 0.09% |
| Geode Capital Management LLCas of 31 Dec 2023 | 11.96k | 0.09% |
| UBS Securities LLCas of 31 Dec 2023 | 5.50k | 0.04% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2023 | 1.50k | 0.01% |
| CWM LLCas of 31 Mar 2024 | 1.00k | 0.01% |
| Qube Research & Technologies Ltd.as of 31 Dec 2023 | 54.00 | 0.00% |
| Armistice Capital LLCas of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 29 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
